ASCENDIA PHARMA SOLUTIONS
Dead / Abandoned — Abandoned — after publication (as of 10 Jul 2024)
What this means for you
This application is over — abandoned 09 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97008771
- Mark type
- Stylized text
- Filed
- 02 Sept 2021
- Published for opposition
- 12 Jul 2022
- Abandoned
- 09 Jul 2024
- Attorney of record
- James Klobucar
Goods and services
- Class 042 — Scientific and technological services: research and development of pharmaceuticals designed via physical means to be released into the body over a period of time
Owner
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
Prosecution history
- 10 Jul 2024 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 10 Jul 2024 — ABANDONMENT - AFTER PUBLICATION
- 09 Jul 2024 — TEAS EXPRESS ABANDONMENT RECEIVED
- 13 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2024 — SOU EXTENSION 3 GRANTED
- 12 Feb 2024 — SOU EXTENSION 3 FILED
- 12 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 25 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2023 — SOU EXTENSION 2 GRANTED
- 23 Aug 2023 — SOU EXTENSION 2 FILED
- 23 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 08 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2023 — SOU EXTENSION 1 GRANTED
- 06 Mar 2023 — SOU EXTENSION 1 FILED
- 06 Mar 2023 — SOU TEAS EXTENSION RECEIVED